Predictive risk factors for postoperative tetany in female patients with Graves' disease

被引:34
作者
Yamashita, H [1 ]
Noguchi, S [1 ]
Murakami, T [1 ]
Uchino, S [1 ]
Watanabe, S [1 ]
Ohshima, A [1 ]
Toda, M [1 ]
Yamashita, H [1 ]
Kawamoto, H [1 ]
机构
[1] Noguchi Thyroid Clin & Hosp Fdn, Oita 8740932, Japan
关键词
D O I
10.1016/S1072-7515(01)00803-1
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Postoperative tetany occurs in patients with secondary hyperparathyroidism caused by a deficiency in calcium and vitamin D concomitant with transient hypoparathyroidism induced by surgery In the present study we further clarified the risk factors by referring to serum 25-hydroxyvitamin D [25(OH)D] and alkaline phosphatase. STUDY DESIGN: The serum levels of intact parathyroid hormone, calcium and other electrolytes. and 25-hydroxyvitamin D [25(OH)D] were measured preoperatively in 178 female patients with Graves' disease who underwent subtotal thyroidectomy. RESULTS: Of the 178 female patients, 15 (8.4%) developed tetany. Univariate analysis of 16 possible risk factors showed that 2 were statistically significant: serum 25(OH)D and alkaline phosphatase levels. The incidence of tetany according to the serum levels of 25(OH)D and alkaline phosphatase was 19.1% (9/47) in patients with 25(OH)D less than or equal to 25 nmol/L and alkaline phosphatase > 155, 11.8%, (4/34) in those with 25(OH)D less than or equal to 25 nmol/L and alkaline phosphatase 155, 6.7% (2/30) in those with 25(OH)D > 25 nmol/L and alkaline phosphatase > 155, and 0% (0/50) in those with 25(OH)D > 25 nmol/L and alkaline phosphatase less than or equal to 155. CONCLUSIONS: Patients with Graves' disease who have vitamin D deficiency with high serum alkaline phosphatase levels are the highest-risk group for postoperative tetany. Serum 25(OH)D and alkaline phosphatase should be monitored in patients with Graves disease. (J Am Coll Surg 2001;192: 465-468. (C) 2001 by the American College of Surgeons).
引用
收藏
页码:465 / 468
页数:4
相关论文
共 13 条
[1]   HYPERCALCEMIA OF THYROTOXICOSIS [J].
BAXTER, JD ;
BONDY, PK .
ANNALS OF INTERNAL MEDICINE, 1966, 65 (03) :429-+
[2]  
ESCOBARJIMENEZ F, 1977, LANCET, V2, P402
[3]  
JONES R M, 1987, Journal of the Royal College of Surgeons of Edinburgh, V32, P24
[4]   SPINAL BONE-MINERAL CONTENT IN MYXEDEMA AND THYROTOXICOSIS - EFFECTS OF THYROID HORMONE(S) AND ANTI-THYROID TREATMENT [J].
KROLNER, B ;
JORGENSEN, JV ;
NIELSEN, SP .
CLINICAL ENDOCRINOLOGY, 1983, 18 (05) :439-446
[5]  
LAITINEN O, 1976, LANCET, V2, P859
[6]  
MICHIE W, 1971, LANCET, V1, P508
[8]   COURSE OF PARTIAL PARATHYROID INSUFFICIENCY AFTER THYROIDECTOMY [J].
WADE, JSH ;
GOODALL, P ;
DEANE, L ;
DAUNCEY, TM ;
FOURMAN, P .
BRITISH JOURNAL OF SURGERY, 1965, 52 (07) :497-+
[9]  
WILKIN TJ, 1977, LANCET, V1, P621
[10]   Postoperative tetany in patients with Graves' disease: a risk factor analysis [J].
Yamashita, H ;
Noguchi, S ;
Tahara, K ;
Watanabe, S ;
Uchino, S ;
Kawamoto, H ;
Toda, M ;
Murakami, N .
CLINICAL ENDOCRINOLOGY, 1997, 47 (01) :71-77